MREO Stock Price | Mereo BioPharma Group PLC ADR Stock Quote (U.S.: Nasdaq) | MarketWatch

By MarketWatch | Jun 14, 2024 at 01:25 PM EST

Mereo BioPharma Group Plc is a biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. Founded in 2015 in London, they have a portfolio of innovative drugs like Etigilimab and Navicixizumab.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.